Sort
326,823 grants matching “clinical trial”
In vivo proton MRS studies:cerebral injury in HIV infection
$2,080,218Bradford A Navia · Tufts University Boston · R01 · FY2009 · NS
Establishing Moderators/Biosignatures of Antidepressant Response- Clinical Care
$2,080,159Madhukar H Trivedi · Ut Southwestern Medical Center · U01 · FY2010 · MH
Wisconsin NCI Community Oncology Research Program (WiNCORP)
$2,080,158Adedayo A Onitilo · Marshfield Clinic Research Foundation · UG1 · FY2018 · CA
Innate Immunity: Elucidation and Modulation for Cancer Therapy
$2,080,062Michael A Caligiuri · Ohio State University · P01 · FY2010 · CA
Biology & Transplantation of the Human Stem Cell
$2,080,053Philip McGlave · University Of Minnesota · P01 · FY2008 · CA
Substance Abuse Research - Medications Development Center
$2,079,960Frederick Gerard Moeller · University Of Texas Hlth Sci Ctr Houston · P50 · FY2010 · DA
Development of MMP-9 inhibitory monoclonal antibodies to relieve neuropathic pain
$2,079,796Xin Ge · University Of Texas Hlth Sci Ctr Houston · UG3 · FY2025 · NS
A Comparative Effectiveness & Long-term Health Study in Wisconsin Smokers
$2,079,714Michael C Fiore · University Of Wisconsin-Madison · R01 · FY2014 · HL
Sexually Transmitted Infections Clinical Trials Group: Development and Validation of Diagnostic Tools for Drug Resistant STIs
$2,079,705Edward Hook · University Of Alabama At Birmingham · N01 · FY2018 · AI
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,079,438Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Rush Center for Urban Health Equity
$2,079,395Lynda H Powell · Rush University Medical Center · P50 · FY2010 · HL
DF/HCC Prostate SPORE
$2,079,312Himisha Beltran · Dana-Farber Cancer Inst · P50 · FY2025 · CA
Selective Targeting of Pancreatic Cancer SPORE
$2,079,098Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2024 · CA
Messenger RNA immunogens for initiation of HIV V3-glycan neutralizing B cell lineages
$2,079,017Barton F Haynes · Duke University · U19 · FY2018 · AI
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,078,938Christopher K Glass · University Of California, San Diego · P01 · FY2024 · HL
ALZHEIMERS DISEASE PREVENTION TRIAL WITH ESTROGENS
$2,078,846Columbia University Health Sciences · R01 · FY2000 · AG
YALE COMPREHENSIVE CANCER CENTER
$2,078,823Yale University · P30 · FY2002 · CA
Irreversible Kidney Injury in Renovascular Hypertension
$2,078,762Lilach O Lerman · Mayo Clinic Rochester · P01 · FY2009 · HL
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS
$2,078,465University Of North Carolina Chapel Hill · U01 · FY2005 · AI
Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance
$2,078,428Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2019 · CA
SAN DIEGO AIDS CLINICAL TRIAL UNIT
$2,078,195University Of California San Diego · U01 · FY2003 · AI
BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial
$2,078,174Daniel F Hanley · Johns Hopkins University · R01 · FY2021 · AG
NORTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$2,077,986Robert L. Murphy · Northwestern University At Chicago · U01 · FY2006 · AI
Clinical Validation Center for Lung Cancer Early Detection
$2,077,743Samir M Hanash · University Of Tx Md Anderson Can Ctr · U01 · FY2025 · CA
Ex Vivo Imaging of the Aging Brain to Discover Morphology/Pathology Associations
$2,077,693Paul A. Yushkevich · University Of Pennsylvania · RF1 · FY2023 · AG